References/Publications for Lymphocyte proliferation assay of Fel d 1

Check all              

Select PubMed ID Description
10808174 J Allergy Clin Immunol. 2000 May;105(5):933-42.

Children at risk for asthma: home allergen levels, lymphocyte proliferation, and
wheeze.

Finn PW(1), Boudreau JO, He H, Wang Y, Chapman MD, Vincent C, Burge HA, Weiss ST,
Perkins DL, Gold DR.


11544452 J Allergy Clin Immunol. 2001 Sep;108(3):349-56.

Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear
cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics,
and normal controls to peptides derived from Fel d 1 chain 1.

Haselden BM(1), Syrigou E, Jones M, Huston D, Ichikawa K, Chapman MD, Kay AB,
Larché M.


12532112 J Allergy Clin Immunol. 2003 Jan;111(1):155-61.

A double-blind, placebo-controlled immunotherapy dose-response study with
standardized cat extract.

Ewbank PA(1), Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS.


14978075 J Immunol. 2004 Mar 1;172(5):2763-72.

A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in
development of the modified Th2 response to cat allergen.

Reefer AJ(1), Carneiro RM, Custis NJ, Platts-Mills TA, Sung SS, Hammer J,
Woodfolk JA.


15102083 J Invest Dermatol. 2004 Apr;122(4):927-36.

T cell epitope-specific defects in the immune response to cat allergen in
patients with atopic dermatitis.

Carneiro R(1), Reefer A, Wilson B, Hammer J, Platts-Mills T, Custis N, Woodfolk
J.


15546862 J Biol Chem. 2005 Feb 4;280(5):3208-16. Epub 2004 Nov 15.

Molecular characterization of major cat allergen Fel d 1: expression of
heterodimer by use of a baculovirus expression system.

Seppälä U(1), Hägglund P, Wurtzen PA, Ipsen H, Thorsted P, Lenhard T, Roepstorff
P, Spangfort MD.


15898990 Clin Exp Allergy. 2005 May;35(5):657-63.

Rational design of hypoallergens applied to the major cat allergen Fel d 1.

Saarne T(1), Kaiser L, Grönlund H, Rasool O, Gafvelin G, van Hage-Hamsten M.


16160912 J Clin Immunol. 2005 Sep;25(5):437-44.

The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13
and IFN-gamma secretion.

Gibbons FK(1), Israel E, Deykin A, Schaub B, He HZ, Perkins DL, Finn PW.


17543334 J Mol Biol. 2007 Jul 20;370(4):714-27. Epub 2007 May 10.

Structural characterization of the tetrameric form of the major cat allergen Fel
d 1.

Kaiser L(1), Velickovic TC, Badia-Martinez D, Adedoyin J, Thunberg S, Hallén D,
Berndt K, Grönlund H, Gafvelin G, van Hage M, Achour A.


18087156 Int Arch Allergy Immunol. 2008;146(1):1-10. Epub 2007 Dec 14.

Low levels of endotoxin enhance allergen-stimulated proliferation and reduce the
threshold for activation in human peripheral blood cells.

Velickovic TC(1), Thunberg S, Polovic N, Neimert-Andersson T, Grönlund H, van
Hage M, Gafvelin G.


18086491 J Allergy Clin Immunol. 2008 Mar;121(3):756-762.e4. Epub 2007 Dec 20.

Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in
subjects with cat allergy.

Hulse KE(1), Reefer AJ, Engelhard VH, Satinover SM, Patrie JT, Chapman MD,
Woodfolk JA.


23268458 World Allergy Organ J. 2011 Jul;4(7):113-9. doi: 10.1097/WOX.0b013e3182228a39.
Epub 2011 Jul 14.

Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible
Biological Activity But Retained Immunogenicity.

Versteeg SA(1), Bulder I, Himly M, van Capel TM, van den Hout R, Koppelman SJ, de
Jong EC, Ferreira F, van Ree R.


24934402 Allergy. 2014 Sep;69(9):1162-70. doi: 10.1111/all.12461. Epub 2014 Jul 12.

Immune regulation by intralymphatic immunotherapy with modular allergen
translocation MAT vaccine.

Zaleska A(1), Eiwegger T, Soyer O, van de Veen W, Rhyner C, Soyka MB, Bekpen C,
Demiröz D, Treis A, Söllner S, Palomares O, Kwok WW, Rose H, Senti G, Kündig TM,
Ozoren N, Jutel M, Akdis CA, Crameri R, Akdis M.


29906527 J Allergy Clin Immunol. 2018 Jun 12. pii: S0091-6749(18)30851-0. doi:
1016/j.jaci.2018.03.023. [Epub ahead of print]

Induction of bystander tolerance and immune deviation after Fel d 1 peptide
immunotherapy.

Moldaver DM(1), Bharhani MS(1), Rudulier CD(2), Wattie J(1), Inman MD(1), Larché
M(3).